These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1599408)

  • 1. Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation by human liver homogenates and by human platelets.
    Bronfman M; Morales MN; Amigo L; Orellana A; Nuñez L; Cárdenas L; Hidalgo PC
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):289-95. PubMed ID: 1599408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters.
    Bronfman M; Amigo L; Morales MN
    Biochem J; 1986 Nov; 239(3):781-4. PubMed ID: 3827829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nafenopin-, ciprofibroyl-, and palmitoyl-CoA conjugation in vitro: kinetic and molecular characterization of marmoset liver microsomes and expressed MLCL1.
    Drogemuller CJ; Nunthasomboon S; Knights KM
    Arch Biochem Biophys; 2001 Dec; 396(1):56-64. PubMed ID: 11716462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
    Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular distribution and characteristics of ciprofibroyl-CoA synthetase in rat liver. Its possible identity with long-chain acyl-CoA synthetase.
    Amigo L; McElroy MC; Morales MN; Bronfman M
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):283-7. PubMed ID: 1599407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes.
    Orellana A; Holuigue L; Hidalgo PC; Faúndez V; González A; Bronfman M
    Eur J Biochem; 1993 Aug; 215(3):903-6. PubMed ID: 8354295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saturable binding sites for the coenzyme A ester of nafenopin, a peroxisome proliferator, in rat liver cytosol.
    Morgan C; Bronfman M
    Xenobiotica; 1995 Dec; 25(12):1293-300. PubMed ID: 8719905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenobiotic acyl-CoA formation: evidence of kinetically distinct hepatic microsomal long-chain fatty acid and nafenopin-CoA ligases.
    Knights KM; Roberts BJ
    Chem Biol Interact; 1994 Mar; 90(3):215-23. PubMed ID: 8168170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxic effects of selected peroxisome proliferators.
    Reisenbichler H; Eckl PM
    Mutat Res; 1993 Apr; 286(2):135-44. PubMed ID: 7681524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic characteristics of rat liver peroxisomal nafenopin-CoA ligase.
    Roberts BJ; MacLeod JK; Singh I; Knights KM
    Biochem Pharmacol; 1995 May; 49(9):1335-9. PubMed ID: 7763316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evidence for involvement of CoA thioesters in peroxisome proliferation and hypolipidaemia.
    Tomaszewski KE; Melnick RL
    Biochim Biophys Acta; 1994 Jan; 1220(2):118-24. PubMed ID: 7906145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of evidence for a hepatic peroxisome proliferator receptor and an explanation for the binding of hypolipidaemic drugs to liver homogenates.
    Milton MN; Elcombe CR; Kass GE; Gibson GG
    Biochem Pharmacol; 1988 Mar; 37(5):793-8. PubMed ID: 3345197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypolipidemic drug metabolites nafenopin-CoA and ciprofibroyl-CoA are competitive P2Y1 receptor antagonists.
    Coddou C; Loyola G; Boyer JL; Bronfman M; Huidobro-Toro JP
    FEBS Lett; 2003 Feb; 536(1-3):145-50. PubMed ID: 12586354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures.
    Tomaszewski KE; Heindel SW; Jenkins WL; Melnick RL
    Toxicology; 1990 Dec; 65(1-2):49-60. PubMed ID: 2274969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
    Perrone CE; Shao L; Williams GM
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-binding protein: identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate-binding proteins from rat liver.
    Lalwani ND; Alvares K; Reddy MK; Reddy MN; Parikh I; Reddy JK
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5242-6. PubMed ID: 3474650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in rat primary hepatocyte culture by peroxisome proliferators.
    Bell DR; Elcombe CR
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):249-53. PubMed ID: 1720616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds.
    Lalwani ND; Fahl WE; Reddy JK
    Biochem Biophys Res Commun; 1983 Oct; 116(2):388-93. PubMed ID: 6651818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
    Graham MJ; Winham MA; Old SL; Gray TJ
    Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
    Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.